Chua Han Chow, Chebib Mary
Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Adv Pharmacol. 2017;79:1-34. doi: 10.1016/bs.apha.2017.03.003. Epub 2017 May 2.
GABA receptors (GABARs) are a class of ligand-gated ion channels with high physiological and therapeutic significance. In the brain, these pentameric receptors occur with diverse subunit composition, which confers highly complex pharmacology to this receptor class. An impressive range of clinically used therapeutics are known to bind to distinct sites found on GABARs to modulate receptor function. Numerous experimental approaches have been used over the years to elucidate the binding sites of these drugs, but unequivocal identification is challenging due to subtype- and ligand-dependent pharmacology. Here, we review the current structural and pharmacological understanding of GABARs, besides highlighting recent evidence which has revealed greater complexity than previously anticipated.
γ-氨基丁酸受体(GABARs)是一类具有高度生理和治疗意义的配体门控离子通道。在大脑中,这些五聚体受体以多种亚基组成形式存在,赋予了这一类受体高度复杂的药理学特性。已知一系列临床上使用的治疗药物可与GABARs上不同的位点结合,从而调节受体功能。多年来,人们采用了多种实验方法来阐明这些药物的结合位点,但由于亚型和配体依赖性药理学,明确的鉴定具有挑战性。在这里,我们除了强调最近揭示出比先前预期更复杂的证据外,还综述了目前对GABARs的结构和药理学理解。